Keywords: expanded, indication, pfizer, aromasin, drugs, giant, says

Expanded indication for Pfizer's Aromasin

Article | 19 September 2005

Print This

Drugs giant Pfizer says that its aromatase inhibitor Aromasin (exemestane) can now be prescribed to postmenopausal women with early breast ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in